Media coverage
9Media coverage
Title Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 Media name/outlet Red Orbit Country United States Date 5/31/15 Persons Ruben Mesa Title Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 Media name/outlet Tutorial Finder Country United States Date 5/30/15 Persons Ruben Mesa Title Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 Media name/outlet Review Seeker Country United States Date 5/30/15 Persons Ruben Mesa Title Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 Media name/outlet USA Life Sciences Database Country Switzerland Date 5/30/15 Persons Ruben Mesa Title Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 Media name/outlet Financial Content Country United States Date 5/30/15 Persons Ruben Mesa Title Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 Media name/outlet Biotechgate Country Switzerland Date 5/30/15 Persons Ruben Mesa Title Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 Media name/outlet Asian Hospital & Healthcare Management Country India Date 5/30/15 Persons Ruben Mesa Title Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 Media name/outlet PipelineReview Country Spain Date 5/30/15 Persons Ruben Mesa Title Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 Media name/outlet Pharmacy Choice Country United States Date 5/30/15 Persons Ruben Mesa